中缝背核
胶质纤维酸性蛋白
中脑
小胶质细胞
免疫组织化学
汤剂
血清素
失眠症
腹腔注射
内科学
药理学
麻醉
医学
内分泌学
中枢神经系统
受体
5-羟色胺能
炎症
出处
期刊:Chinese Journal of Experimental Traditional Medical Formulae
日期:2012-01-01
被引量:1
摘要
Objective:To explore the effect of Suanzaoren decoction(SZRD) on the expression of astrocytes and microglia cells in the dorsal raphe nuclei(DRN) insomnia rats.Method: The insomnia rat model was established by intraperitoneal injection of DL-4-Chlorophenylalanine(PCPA)at the dose of 350 mg · kg-1 for two days.Rats were divided into control group,model group,SZRD groups,and estazolam group.The SZRD groups were treated by intragastric administration of SZRD at 15,7.5,3.75 g · kg-1 each day for seven days.The estazolam group was treated the same way using estazolam at 2 mg · kg-1 for 7 days.HE staining was use to check the neural damage in the DRN and test animal's midbrain glial fibrillary acidic protein(GFAP);and OX42 expression was examined using immunohistochemical staining.Result: The level of neural damage in the DRN was significantly higher in the insomnia model group than in the control group(P0.01).Insomnia model group rats showed significantly higher levels(P0.01) of GFAP and OX42 positive cells in the DRN than control animals.Treatment animals receiving a high dose of SZRD(15 g · kg-1) showed significantly lower levels(P0.01) of GFAP and OX42 positive cells in the DRN than insomnia model group animals.This treatment group showed no significant difference when compared to animals treated using estazolam.Conclusion: PCPA can damage the DRN neurons.Insomnia induced by PCPA can activate midbrain astrocytes and microglia.SZRD reduces midbrain GFAP and OX42 expression,and reduces the damage from PCPA.This may be one of the mechanisms for SZRD in treatment of insomnia.
科研通智能强力驱动
Strongly Powered by AbleSci AI